Jan Steffen

1.7k total citations
38 papers, 1.3k citations indexed

About

Jan Steffen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jan Steffen has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Genetics. Recurrent topics in Jan Steffen's work include DNA Repair Mechanisms (9 papers), BRCA gene mutations in cancer (7 papers) and Ovarian cancer diagnosis and treatment (5 papers). Jan Steffen is often cited by papers focused on DNA Repair Mechanisms (9 papers), BRCA gene mutations in cancer (7 papers) and Ovarian cancer diagnosis and treatment (5 papers). Jan Steffen collaborates with scholars based in Poland, Germany and Switzerland. Jan Steffen's co-authors include Theodore T. Puck, Janina Kamińska, W. Ruka, Piotr Rutkowski, M Kowalska, A. S. Michalowski, Magdalena Chechlińska, Dorota Nowakowska, A. Michałowski and Małgorzata Fuksiewicz and has published in prestigious journals such as PLoS ONE, Biophysical Journal and Annals of Oncology.

In The Last Decade

Jan Steffen

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Steffen Poland 19 656 404 285 235 198 38 1.3k
B. Schütte Netherlands 20 718 1.1× 436 1.1× 440 1.5× 147 0.6× 161 0.8× 47 1.8k
Beverly D. Smolich United States 15 973 1.5× 402 1.0× 211 0.7× 88 0.4× 96 0.5× 17 1.7k
Timothy J. O’Brien United States 21 522 0.8× 208 0.5× 147 0.5× 143 0.6× 318 1.6× 48 1.7k
Jeanne E. Anderson United States 28 961 1.5× 682 1.7× 154 0.5× 227 1.0× 495 2.5× 86 3.7k
Yunguang Sun United States 20 948 1.4× 439 1.1× 529 1.9× 116 0.5× 187 0.9× 58 1.5k
Meng Su China 24 1.1k 1.7× 318 0.8× 491 1.7× 173 0.7× 149 0.8× 74 1.8k
P J Stambrook United States 28 1.6k 2.5× 774 1.9× 454 1.6× 363 1.5× 120 0.6× 60 2.3k
Annemieke de Vries Netherlands 26 1.2k 1.9× 918 2.3× 506 1.8× 295 1.3× 120 0.6× 60 2.1k
Frank J. Calzone United States 23 1.6k 2.4× 403 1.0× 193 0.7× 567 2.4× 98 0.5× 43 2.1k
Carl N. Sprung Australia 26 752 1.1× 210 0.5× 207 0.7× 146 0.6× 176 0.9× 50 1.4k

Countries citing papers authored by Jan Steffen

Since Specialization
Citations

This map shows the geographic impact of Jan Steffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Steffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Steffen more than expected).

Fields of papers citing papers by Jan Steffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Steffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Steffen. The network helps show where Jan Steffen may publish in the future.

Co-authorship network of co-authors of Jan Steffen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Steffen. A scholar is included among the top collaborators of Jan Steffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Steffen. Jan Steffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barinoff, Jana, Alexander Traut, Dirk Bauerschlag, et al.. (2013). Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group. Geburtshilfe und Frauenheilkunde. 73(5). 433–439. 3 indexed citations
2.
Gaj, Paweł, Anna Kluska, Dorota Nowakowska, et al.. (2013). Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer. Familial Cancer. 12(4). 691–698. 2 indexed citations
3.
Brożek, Izabela, Magdalena Ratajska, Magdalena Piątkowska, et al.. (2012). Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases. Familial Cancer. 11(3). 351–354. 20 indexed citations
4.
Noske, Aurelia, Sibylle Loibl, Silvia Darb‐Esfahani, et al.. (2010). Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765). Breast Cancer Research and Treatment. 126(1). 109–117. 47 indexed citations
5.
Nowakowska, Dorota, et al.. (2010). First Polish Cowden syndrome patient with confirmed PTEN gene mutation. Archives of Medical Science. 1(1). 135–137. 1 indexed citations
6.
Chechlińska, Magdalena, Jan Konrad Siwicki, Monika Goś, et al.. (2009). Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal. BMC Genomics. 10(1). 261–261. 11 indexed citations
7.
Siwicki, Jan Konrad, Grzegorz Rymkiewicz, Piotr Kuźniar, et al.. (2007). Spontaneously immortalized T lymphocytes from Nijmegen Breakage Syndrome patients display phenotypes typical for lymphoma cells. Leukemia Research. 32(4). 569–577. 2 indexed citations
8.
Kamińska, Janina, M Kowalska, Beata Kotowicz, et al.. (2006). Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis. Oncology. 70(2). 115–125. 104 indexed citations
9.
Steffen, Jan, et al.. (2006). Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. International Journal of Cancer. 119(2). 472–475. 81 indexed citations
10.
Niwińska, Anna, et al.. (2006). Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland.. PubMed. 53(4). 305–8. 7 indexed citations
11.
Pławski, Andrzej, et al.. (2006). The AAPC case, with an early onset of colorectal cancer. International Journal of Colorectal Disease. 22(4). 449–451. 7 indexed citations
12.
Utracka-Hutka, B., et al.. (2004). BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. Annals of Oncology. 15(9). 1373–1376. 30 indexed citations
13.
Steffen, Jan, Raymonda Varon, Maria Mosor, et al.. (2004). Increased cancer risk of heterozygotes with NBS1 germline mutations in poland. International Journal of Cancer. 111(1). 67–71. 98 indexed citations
14.
Dansonka‐Mieszkowska, Agnieszka, et al.. (2002). Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours. Annals of Human Genetics. 66(6). 353–359. 25 indexed citations
15.
Rutkowski, Piotr, Janina Kamińska, M Kowalska, W. Ruka, & Jan Steffen. (2002). Cytokine serum levels in soft tissue sarcoma patients: Correlations with clinico‐pathological features and prognosis. International Journal of Cancer. 100(4). 463–471. 93 indexed citations
16.
17.
Steffen, Jan & A. S. Michalowski. (1973). Heterogenous chromosomal radiosensitivity of phytohaemagglutinin-stimulated human blood lymphocytes in culture. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 17(3). 367–376. 49 indexed citations
18.
Steffen, Jan & L. Sörén. (1968). Changes in dry mass of PHA stimulated human lymphocytes during blast transformation. Experimental Cell Research. 53(2-3). 652–659. 10 indexed citations
19.
Steffen, Jan. (1966). [Blastic transformation of the lymphocyte outside of the organism].. PubMed. 4(4). 419–24. 2 indexed citations
20.
Puck, Theodore T. & Jan Steffen. (1963). Life Cycle Analysis of Mammalian Cells. Biophysical Journal. 3(5). 379–397. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Schütte Breakdown of academic impact, for papers by Beverly D. Smolich Breakdown of academic impact, for papers by Timothy J. O’Brien Breakdown of academic impact, for papers by Jeanne E. Anderson Breakdown of academic impact, for papers by Yunguang Sun Breakdown of academic impact, for papers by Meng Su Breakdown of academic impact, for papers by P J Stambrook Breakdown of academic impact, for papers by Annemieke de Vries Breakdown of academic impact, for papers by Frank J. Calzone Breakdown of academic impact, for papers by Carl N. Sprung
Rankless by CCL
2026